Ozanta Semaglutide Injection 8 mg in 3 ml

AboutOzanta 8 mg in 3 ml is a prefilled semaglutide injection pen presentation used under medical supervision for approved diabetes or weight-management indications, depending on the local product authorisation. It is supplied as a multidose pen and must be used only according to the prescribing information.Usage InstructionsInject subcutaneously once weekly on the same day, at the dose prescribed. Use the pen only as instructed by a healthcare professional. Do not share the pen, even if the needle is changed. Dispose of needles safely after each use.BenefitsMay improve blood glucose control in Type 2 diabetes and may support weight reduction when prescribed for an approved indication.How it WorksSemaglutide is a glucagon-like peptide-1 receptor agonist. It increases glucose-dependent insulin release, reduces inappropriate glucagon secretion, slows gastric emptying and may reduce appetite.Side EffectsNausea, vomiting, diarrhoea, constipation, abdominal pain, reduced appetite and injection-site reactions may occur. Seek urgent care for severe persistent abdominal pain, repeated vomiting, dehydration, symptoms of gallbladder disease or allergic reaction.Safety AdvicePrescription use only. Do not use in pregnancy unless specifically directed. Tell the doctor about pancreatitis, gallbladder disease, diabetic eye disease, kidney disease, severe gastrointestinal disease and all diabetes medicines. It is not insulin and should not be substituted for insulin without medical supervision.StorageStore refrigerated at 2°C to 8°C before first use. Do not freeze or place next to the freezer compartment. Protect from light. After opening, follow the exact in-use storage period and temperature stated on the product label.